North America Coronary Stents Market (2016-2022)

Date: 2016-11
Pages:84
Price:

“The North America coronary stent market was estimated to attain a market size of $3 billion in 2015 and is expected to grow at a CAGR of 5.4 % during the forecast period (2016 – 2022).
The U.S region would continue its dominance and would attain a market size of $2.9 billion by 2022. The Drug Eluting Stents segment is expected to further grow at a CAGR of 4.6% during the forecast period thereby maintaining its dominance in the North America market. However, the Bioresorable Vascular Scaffold segment would grow at the highest CAGR.
The coronary stent market is segmented on the basis of products into bare metal stents, Drug-Eluting Stents (DES), and Bioresorbable Vascular Scaffold (BVS). DES is further sub segmented into biodegradable and nonbiodegradable stents. DES was the leading product within the market segments.
One of the significant benefits of DES is its ability to release antiproliferative drug that avoids neointimal proliferation, reducing the incidences of stent restenosis; therefore, non-invasive procedures offered by DES is gaining prominence and has led to the market dominance during the year 2015.
On the other hand, Bioresorbable Vascular Scaffold is anticipated to be the fastest growing market segment and is anticipated to grow exponentially during the forecast period. As an example to its potential, in July 2016, the U.S. FDA approved the first absorbable stent Absorb GT1 BVS for arterial disorder. The product is manufactured with biodegradable polymer poly(L-lactide). BVS is advantageous over other forms for restoring vasomotor function, expanding future treatment options, and helping avoid future complications with permanent devices.
The report aims at providing stakeholders with an in-depth analysis of the North America Coronary stents market. The current & future market trends of the technology are pinpointed in a highly strategic manner. With the report in hand, investors can gain highly strategic market insights to base their discretion for investments. Market estimation of the current market and estimations through 2016-2022 would provide the complete financial potency of the market.
Key market participants profiled in the report includes Abbott, Boston Scientific Corporation, Medtronic, Terumo Corporation, B. Braun Melsungen AG, Stentys SA, MicroPort Scientific Corporation and C. R. Bard, Inc.

Categories

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample